Tenaya Therapeutics, Inc. (TNYA)
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.
Address
171 OYSTER POINT BLVD., SUITE 500
SOUTH SAN FRANCISCO, CA 94080
Founded
2016
Number of Employees
140
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)